The National Institute for Bioprocessing Research and Training's (NIBRT) mission is to support the growth and development of all aspects of the biopharmaceutical industry in Ireland by becoming a global leader in biopharmaceutical manufacturing research, education and training.
The NIBRT performs high impact, world class, industry-aligned research in all aspects of bioprocessing, biopharmaceutical manufacturing, therapeutic protein characterisation, compliance and regulation. Research is conducted via a wide variety of industry-friendly mechanisms including consultancy, contact and collaborative research programmes. The Institute’s research partners include companies such as MSD, Lilly, Sanofi-Genzyme, BioMarin, Pfizer, Waters and Agilent. The NIBRT also designs, develops and delivers best-in-class education and training solutions for biopharmaceutical manufacturing across all levels to national and international students and workforces. Training clients include companies such as Amgen, MSD, Lilly, Sanofi-Genzyme, Regeneron, BioMarin, Jazz and Alexion.
The NIBRT provides state-of-the-art biopharmaceutical manufacturing facilities (6,500m2) for research, process development and training activities. The Institute has won numerous national and international awards including: the ISPE/Interphex Facility of the Year Award; Bioprocess International Manufacturing Collaboration of the Decade, Waters Centre of Innovation; and, the Taoiseach’s Public Service Excellence Awards.
- Biopharmaceutical manufacturing
- Bioanalytics and product characterisation
- Process analytical technologies/quality by design
- Process development and optimisation
- Customised training and education programmes
Research performed by:
- University College Dublin
- Trinity College Dublin
- Dublin City University
- Institute of Technology Sligo
- Synthesis and Solid State Pharmaceutical Centre (SSPC)
- NUI Galway